203 related articles for article (PubMed ID: 3140583)
1. Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies.
Hull MG
Gynecol Endocrinol; 1987 Sep; 1(3):235-45. PubMed ID: 3140583
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of ovarian cauterization and gonadotropin-releasing hormone agonist and oral contraceptive therapy combination on endocrine changes in women with polycystic ovary disease.
Taskin O; Yalcinoglu AI; Kafkasli A; Burak F; Ozekici U
Fertil Steril; 1996 Jun; 65(6):1115-8. PubMed ID: 8641482
[TBL] [Abstract][Full Text] [Related]
3. Clinical uses of multiple serum FSH and LH measurements in patients with amenorrhea and infertility.
Friedman S
Obstet Gynecol; 1973 Jun; 41(6):809-17. PubMed ID: 4736128
[No Abstract] [Full Text] [Related]
4. Pulsatile luteinizing hormone patterns in the follicular phase of the menstrual cycle, polycystic ovarian disease (PCOD) and non-PCOD secondary amenorrhea.
Burger CW; Korsen T; van Kessel H; van Dop PA; Caron FJ; Schoemaker J
J Clin Endocrinol Metab; 1985 Dec; 61(6):1126-32. PubMed ID: 3932449
[TBL] [Abstract][Full Text] [Related]
5. Endocrinological environment of polycystic ovarian disease.
Tanaka T; Fujimoto S
Horm Res; 1990; 33 Suppl 2():5-9. PubMed ID: 2128882
[TBL] [Abstract][Full Text] [Related]
6. Resistant cases of polycystic ovarian disease successfully treated with a combination of corticosteroids, clomiphene, and bromocriptine.
Homburg R; Ashkenazi J; Goldman J
Int J Fertil; 1988; 33(6):393-7. PubMed ID: 2906913
[TBL] [Abstract][Full Text] [Related]
7. Polycystic ovarian disease.
Raj SG; Talbert LM
Obstet Gynecol Annu; 1984; 13():261-73. PubMed ID: 6232474
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor alpha versus LH and androstendione as a reliable predictor of spontaneous ovulation after laparoscopic ovarian drilling for women with clomiphene citrate resistance polycystic ovarian disease.
Seyam E; Hefzy E
Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():126-133. PubMed ID: 29408743
[TBL] [Abstract][Full Text] [Related]
9. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease.
Fauser BC; Pache TD; Lamberts SW; Hop WC; de Jong FH; Dahl KD
J Clin Endocrinol Metab; 1991 Oct; 73(4):811-7. PubMed ID: 1909705
[TBL] [Abstract][Full Text] [Related]
10. Women with clomiphene citrate resistant polycystic ovarian disease: predictors of spontaneous ovulation after laparoscopic ovarian drilling.
Abuelghar WM; Bayoumy HA; Ellaithy MI; Khalil MS
Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():178-85. PubMed ID: 24576485
[TBL] [Abstract][Full Text] [Related]
11. Ovulation induction with pulsatile luteinizing releasing hormone in women with clomiphene citrate-resistant polycystic ovary-like disease: clinical results.
Burger CW; Korsen TJ; Hompes PG; van Kessel H; Schoemaker J
Fertil Steril; 1986 Dec; 46(6):1045-54. PubMed ID: 3096792
[TBL] [Abstract][Full Text] [Related]
12. Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients.
Balen AH; Conway GS; Kaltsas G; Techatrasak K; Manning PJ; West C; Jacobs HS
Hum Reprod; 1995 Aug; 10(8):2107-11. PubMed ID: 8567849
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
Rebar R; Judd HL; Yen SS; Rakoff J; Vandenberg G; Naftolin F
J Clin Invest; 1976 May; 57(5):1320-9. PubMed ID: 770505
[TBL] [Abstract][Full Text] [Related]
14. Bromocriptine treatment of women with clomiphene-resistant polycystic ovary syndrome.
Polson DW; Mason HD; Franks S
Clin Endocrinol (Oxf); 1987 Feb; 26(2):197-203. PubMed ID: 3117444
[TBL] [Abstract][Full Text] [Related]
15. Pulsatile luteinizing hormone secretion in hypothalamic amenorrhea, anorexia nervosa, and polycystic ovarian disease during naltrexone treatment.
Armeanu MC; Berkhout GM; Schoemaker J
Fertil Steril; 1992 Apr; 57(4):762-70. PubMed ID: 1555686
[TBL] [Abstract][Full Text] [Related]
16. Ovulation induction with subcutaneous pulsatile gonadotropin-releasing hormone in various ovulatory disorders.
Saffan D; Seibel MM
Fertil Steril; 1986 Apr; 45(4):475-82. PubMed ID: 3082681
[TBL] [Abstract][Full Text] [Related]
17. [The "regulating conception-governor vessel" acupuncture method for infertility of polycystic ovarian syndrome].
Zhuo Y; Wu J; Lin W; Pi M; Chen P; Yang Z
Zhongguo Zhen Jiu; 2016 Dec; 36(12):1237-1241. PubMed ID: 29231358
[TBL] [Abstract][Full Text] [Related]
18. Transvaginal ultrasound appearances of the ovary in normal women and hirsute women with oligomenorrhoea.
Fox R
Aust N Z J Obstet Gynaecol; 1999 Feb; 39(1):63-8. PubMed ID: 10099753
[TBL] [Abstract][Full Text] [Related]
19. Selected aspects of polycystic ovarian disease.
Goldzieher JW; Young RL
Endocrinol Metab Clin North Am; 1992 Mar; 21(1):141-71. PubMed ID: 1533584
[TBL] [Abstract][Full Text] [Related]
20. The abnormal response of polycystic ovarian disease patients to exogenous pulsatile gonadotropin-releasing hormone: characterization and management.
Filicori M; Flamigni C; Campaniello E; Valdiserri A; Ferrari P; Meriggiola MC; Michelacci L; Pareschi A
J Clin Endocrinol Metab; 1989 Oct; 69(4):825-31. PubMed ID: 2506216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
